The quality of international normalised ratio control in southern Tasmania

被引：4
作者：
Bereznicki, Luke R. E. [1 ]
Madden, Alexandra R. [2 ]
Peterson, Gregory M. [1 ]
机构：
[1] Univ Tasmania, Sch Pharm, Hobart, Tas, Australia
[2] Royal Hobart Hosp, Dept Pharm, Hobart, Tas, Australia
来源：
MEDICAL JOURNAL OF AUSTRALIA | 2013年 / 198卷 / 06期
关键词：
ATRIAL-FIBRILLATION; DABIGATRAN; WARFARIN;
D O I：
10.5694/mja12.11370
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：315 / 315
页数：1
相关论文
共 5 条
[1]  
[Anonymous], REV ANT THER ATR FIB
[2]   Cost-Effectiveness of Dabigatran for Stroke Prophylaxis in Atrial Fibrillation [J].
Shah, Shimoli V. ;
Gage, Brian F. .
CIRCULATION, 2011, 123 (22) :2562-2570
[3]   Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial [J].
Wallentin, Lars ;
Yusuf, Salim ;
Ezekowitz, Michael D. ;
Alings, Marco ;
Flather, Marcus ;
Franzosi, Maria Grazia ;
Pais, Prem ;
Dans, Antonio ;
Eikelboom, John ;
Oldgren, Jonas ;
Pogue, Janice ;
Reilly, Paul A. ;
Yang, Sean ;
Connolly, Stuart J. .
LANCET, 2010, 376 (9745) :975-983
[4]   Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation A Systematic Review [J].
Wan, Yi ;
Heneghan, Carl ;
Perera, Rafael ;
Roberts, Nia ;
Hollowell, Jennifer ;
Glasziou, Paul ;
Bankhead, Clare ;
Xu, Yongyong .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2008, 1 (02) :84-91
[5]   Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control - Results from SPORTIF III and IV [J].
White, Harvey D. ;
Gruber, Michael ;
Feyzi, Jan ;
Kaatz, Scott ;
Tse, Hung-Fat ;
Husted, Steen ;
Albers, Gregory W. .
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (03) :239-245
1